Mexico Pharma News: Bayer Targets Cancer; Novartis Gets…
The latest news from Mexican pharma, including Bayer’s big bet on oncology and Novartis’ aggressive expansion strategy as well as updates on the…
Tagged with Bayer
Saudization: Local Staffing Obligations & Big Pharma’s…
Historically dependent on oil, Saudi Arabia, like most countries in the Arabian Peninsula, is now investing a large chunk of the sizeable resources…
Top 10 Pharma Companies in France
The Top 10 pharma companies in the EUR 28.9 million French pharma market in 2019. Homegrown players Sanofi and Servier lead the way, followed by…
German Pharma: Highest Honours for BioNTech Founders; Bayer’s…
A roundup of some of the most important recent news from German pharma, including state honours for the founders of BioNTech, the latest on vaccines…
HSA: APAC’s Regulatory Gold Standard
As the most important pharma hub in its region, and one of the most important globally, many companies look to launch new products in Singapore first…
The Long Read / Norway: Unlocking Potential
Equality has long been a deeply held ideal in Norway, where the concept of allemannsretten – the legal right to roam – permeates all aspects of…
Curing the Incurable: Cell & Gene Therapy and A New Age for…
Bayer’s Michael Levy casts his eye over the implications of the advent of cell and gene therapies on pharmacovigilance and patient safety. Levy…
Vincent Ruland – Country Division Head, Bayer…
Bayer’s Dr Vincent Ruland highlights his career trajectory from medical doctor to pharma country manager; the company’s priorities in Malaysia,…
Ethics in Artificial Intelligence: Better Prepare Now for New EU…
With upcoming EU regulation poised to have a massive impact on ethical regulations around AI in Europe, Bayer Head of Digital Transformation Saskia…
Bayer Strategy Head: Big Pharma “Needs to Up its Game”
During the FT Global Pharmaceutical and Biotechnology Conference earlier this week, four Big Pharma and biotech executives spoke about the changing…
Pharmacovigilance: Steadying the Ship Through the COVID-19 Storm
Michael Levy, head of pharmacovigilance at Bayer Pharma and Bayer Consumer Health, makes a compelling case for the critical role of pharmacovigilance…
Market Access in Switzerland: Reimbursement Delays for 76% of New…
Switzerland, rightly regarded as one of the world’s most innovative nations, risks damaging its reputation if innovative new medicines continue to…
